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We developed an animal model reproducing several aspects of Whipple’s disease. Immunocompetent mice
were persistently infected with Tropheryma whipplei, its etiological agent, and developed liver granulomas. SCID
mice were infected similarly but did not develop tissue lesions. The delayed clearance of T. whipplei suggests
a protective role for innate immunity.
Whipple’s disease (WD) is a systemic bacterial infection
characterized by fever, polyarthritis, lymphadenopathy, intes-
tinal manifestations, and, occasionally, cardiac or ocular man-
ifestations. Its diagnosis is based on the identification of
infiltrating large foamy macrophages in duodenal biopsy
specimens (10). In 2000, our group successfully cultured the
agent of WD, officially named Tropheryma whipplei (11), and
two strains were sequenced in 2003 (1, 12). WD is related to
a defective host defense. Indeed, reduced secretion of in-
terleukin-12 (IL-12) is observed in WD patients (9); it likely
leads to diminished gamma interferon (IFN-) production
by T cells and defective macrophage activation. In human
macrophages, T. whipplei replication depends on IL-16 and
requires down-modulation of the IL-12 pathway (5). This is
emphasized in intestinal WD in which infiltrating macro-
phages exhibit an alternative transcription activation phe-
notype (4). The purpose of our study was to develop a
murine model that would emulate human infection. For the
first time, we describe T. whipplei infection in mice with
bacterial persistence and tissue lesions. Such animal models
will facilitate the investigation of WD pathogenesis.
T. whipplei organisms (strain Twist-Marseille) were cultured
on MRC5 cell monolayers as described previously (5). Female
6-week-old immunocompetent mice (BALB/c mice) and
CB-17 mice with severe combined immunodeficiency (SCID
mice) were obtained from Charles River Labs (L’Arbresle,
France). Mice were infected intravenously with 3  105 organ-
isms or phosphate-buffered saline as a control. Animals were
examined daily. Five infected mice and one control mouse of
each group were sacrificed 4, 10, 20, 50, and 70 days after
inoculation. Spleens, livers, hearts, brains, and gastrointestinal
tracts were excised, and a part of each organ was stored at
80°C. The other part was fixed in Bouin’s solution and em-
bedded in paraffin. Sections of paraffin-embedded tissues (5
m) were stained with hematoxylin-eosin. Granulomas were
defined as a compact aggregate of at least five macrophages.
For immunohistologic detection of T. whipplei, paraffin-em-
bedded tissue sections were deparaffinized in xylene and rehy-
drated in graded alcohol. Each tissue section was incubated
with rabbit antibodies to T. whipplei (diluted at 1:2,000). Bac-
teria were revealed using the Immunostain-Plus kit (Zymed,
CliniSciences, Montrouge, France) according to the manufac-
turer’s instructions. The whole tissue area was examined, and
infection was quantified using the image analyzer SAMBA
2005 (Alcatel, Grenoble, France) as previously described (7).
The results are expressed as the number of bacteria found per
mm3 of tissue. Results were expressed as the means standard
deviations.
We demonstrated in this study that BALB/c mice can be
infected with T. whipplei. The organisms were detected in liver
and spleen, which is consistent with the sites of T. whipplei
infection reported for WD patients (14). Moreover, hepato-
megaly and/or splenomegaly has been observed in WD pa-
tients (6). Infected cells were randomly distributed throughout
the hepatic parenchyma. Bacteria were detected at day 4
postinfection (about 50 organisms per mm3 tissue) and were
localized in both macrophages and sinusoidal cells, which were
presumably Kupffer cells (Fig. 1A). Mice progressively cleared
the organisms, which were undetectable in the liver at 70 days
postinfection (Fig. 1B). Infection of the spleen remained min-
imal throughout the duration of the experiment (about 0.2
organism per mm3 tissue), confirming the differences previ-
ously reported for hepatic and splenic immune responses to
infection (2). Gastrointestinal tracts of BALB/c mice were not
infected with T. whipplei, whereas small intestine containing
lamina propria macrophages was the most dominant presen-
tation of WD in humans. Morbidity and mortality of BALB/c
mice were not observed up to 70 days postinfection. Note that
organisms were not found in brain and their usual locations,
such as the gastrointestinal tract and heart. No large foamy
macrophages were seen in BALB/c mice in contrast to that
seen in humans. The inoculation route did not account for such
findings because intraperitoneal injection of T. whipplei in-
duced a pattern of tissue infection similar to that induced by
intravenous injection (data not shown). Small multifocal gran-
ulomas consisting mainly of macrophages and epithelioid cells
were found in the liver of infected mice (Fig. 1C). Their num-
ber was low throughout the experiment (about four granulo-
mas per mm3 tissue). The spleen, gastrointestinal tract, heart,
and brain did not exhibit any lesions, which may be related to
the minimal, or lack of, colonization. In WD patients, besides
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the classical aggregation of foamy macrophages in intestinal
tissue, the liver, lymph nodes, and spleen exhibit noncaseating,
epithelioid cell granulomas. Diffuse granulomatous disease
may characterize WD without obvious enteric symptoms or
signs of disease (13, 15). The granulomatous lesions observed
in our study were similar to the histologic lesions observed in
sarcoidosis-like forms of WD (3). This is likely related to the
early evolution of T. whipplei infection. Indeed, sarcoid-like
reaction is an early manifestation of WD, and in mice, hepatic
granulomas were observed 4 days after infection.
Surprisingly, SCID mice controlled T. whipplei infection as
did BALB/c mice. We did not observe morbidity or mortality
throughout the study. T. whipplei organisms were detected in
the liver but not in the spleen, heart, brain, or intestinal tract.
The bacterial burden was similar to that found in BALB/c mice
at day 4; it decreased thereafter and was undetectable at day 70
(Fig. 1B), demonstrating that SCID mice are able to eliminate
T. whipplei in a time frame similar to that for BALB/c mice.
The infection of SCID mice was not associated with granulo-
mas in the liver. That SCID mice and immunocompetent mice
clear T. whipplei infection in similar ways suggests that T.
whipplei does not behave as an opportunistic infectious agent.
Because WD is characterized by a deficient IL-12/IFN- path-
way (5, 8), one would expect that the T-cell deficiency of SCID
mice and the concomitant impaired Th1 immune response
would result in an increased susceptibility to T. whipplei infec-
tion. Yet, that is not what we observed in this study. It is
possible that the low pathogenicity of T. whipplei accounts for
its ability to control infection in the absence of adaptive im-
munity. Our findings also suggest, however, that IFN- pro-
duced by NK cells may be sufficient to control T. whipplei
infection in mice.
In conclusion, the mouse model of T. whipplei infection
reproduces several features of the human disease, including
bacterial persistence and granulomatous lesions. The key dif-
ferences are the self-limited nature of the infection, the gran-
ulomatous response and anatomical distribution of lesions, and
the overall bacterial burden per granulomatous lesion. How-
ever, this model will enable more-comprehensive investiga-
tions of the pathophysiology of WD.
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